Pharma & Biotech

Financial analysts are expressing growing enthusiasm for Eli Lilly's stock, with multiple firms raising their price projections as the pharmaceutical...

The independent existence of CureVac could soon be a chapter in corporate history. On November 25, shareholders will convene in...

Intellia Therapeutics captured significant market attention on November 16 when the biotechnology firm unveiled groundbreaking clinical trial data for its...

Halozyme Therapeutics is riding a wave of positive developments, with two significant announcements providing substantial momentum for the biotechnology firm....

A biotech firm suddenly flush with cash and developing a revolutionary medical treatment typically represents an investor's ideal scenario. However,...

Annovis Bio shares experienced a dramatic upward move following the release of encouraging clinical trial data for its Parkinson's disease...

Biotechnology firm Kezar Life Sciences is embarking on a fundamental strategic shift after encountering a significant regulatory obstacle. The U.S....

Skye Bioscience's stock is experiencing another significant downturn this week as the biotechnology firm faces a new class-action lawsuit. The...

Bioatla Inc. witnessed a dramatic surge in its share price, climbing nearly 20 percent following the release of its latest...

Investor attention turned to Aclaris Therapeutics this week following the company's presentations at the Jefferies Global Healthcare Conference. The biopharmaceutical...